| Autor: |
Barker M; ri CEDD, GlaxoSmithKline Medicines Research Centre, Stevenage, UK., Clackers M, Demaine DA, Humphreys D, Johnston MJ, Jones HT, Pacquet F, Pritchard JM, Salter M, Shanahan SE, Skone PA, Vinader VM, Uings I, McLay IM, Macdonald SJ |
| Jazyk: |
angličtina |
| Zdroj: |
Journal of medicinal chemistry [J Med Chem] 2005 Jul 14; Vol. 48 (14), pp. 4507-10. |
| DOI: |
10.1021/jm050345y |
| Abstrakt: |
Structurally related glucocorticoid receptor (GR) binders were docked into the GR active site to select the binding mode closest to the true docking mode. This process, termed an "agreement docking method", led to the design of tetrahydronaphthalene 9. The method was validated by the syntheses of 9 and related analogues, which are potent binders of GR. 15a is a partial agonist while 9e and 15a are micromolar antagonists in a mouse mammary tumor virus transactivation assay. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
